Ho Sup Lee
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Ixazomib Maintenance in Patients With Newly Diagnosed Mantle Cell Lymphoma(MCL) (NCT03616782) | Ho Sup Lee | 2018-12-24 |
Track Ho Sup Lee automatically
Every clearance here is in the API, with alerts when new ones post.